The present invention is directed to novel compounds of formula (I):
or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
[EN] The present invention is directed to novel compounds of formula (I): or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors. [FR] L'invention concerne de nouveaux composés de formule (I) ou des dérivés de ceux-ci acceptables sur le plan pharmaceutique, et leur utilisation en tant que produits pharmaceutiques, notamment en tant qu'inhibiteurs de kinase p38.